Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing Functional Impairments in CIPN Patients

Official title: Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Run by Paracelsus Medical University · NCT07315334 · Data updated 2026-11-12

This study tests how CIPN affects daily function by using functional tests alongside patient self-reports to see how well the tests reflect everyday difficulties.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorParacelsus Medical University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Salzburg)
StatusRecruiting
StartedMarch 15, 2026
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedAugust 19, 2026
Trial IDNCT07315334 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with CIPN grade 2 or higher who can stand, walk, and complete questionnaires.

Probably not a fit

Patients with pre-existing non-CIPN neuropathies or conditions severely limiting mobility may not see benefit from these assessments.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional study examines functional impairments in adults with chemotherapy-induced peripheral neuropathy (CIPN) and compares objective functional assessments with patient-reported outcomes. Participants complete questionnaires and undergo physical exams to measure daily activity limitations, gait and balance, and fine motor function. The goal is to better understand how objective tests correlate with patients’ subjective experiences and to identify which assessments best reflect real-world impact of CIPN.

Why it matters

Potential benefit: If successful, the study could improve how CIPN-related disability is measured and monitored in patients receiving chemotherapy.

How similar studies have gone: Previous work suggests objective functional measures can complement patient-reported symptoms in CIPN, but the added value of specific tests like gait and 9-hole peg task needs confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Male and female patients with CIPN grade ≥ 2, according to Common Terminology Criteria for Adverse Events for peripheral sensory or motor neuropathy (CTCAE) version 5

\- Age ≥ 18

\- Ongoing or completed neuropathy-inducing chemotherapy

\- Ability to stand and walk

\- Ability to fill out a questionnaire Inclusion criteria for healthy controls

\- Male and female adults (age ≥ 18)

\- Ability to stand and walk

\- Ability to fill out a questionnaire

Exclusion Criteria:

* Pre-existing clinically manifest peripheral neuropathy prior to start of chemotherapy (e.g. caused by radiation or malignant plexopathy, lumbar or cervical radiculopathy, carpal tunnel syndrome, B12 deficiency, AIDS, monoclonal gammopathy, diabetes, heavy metal poisoning amyloidosis, syphilis, hyperthyroidism or hypothyroidism, inherited neuropathy, etc.)

Acute or chronic injuries/ diseases of the musculoskeletal system affecting functional tests

\- Acute or chronic cardiovascular diseases affecting functional tests

\- Neurological disease affecting functional tests (for healthy controls)

\- Neurological disease other than CIPN affecting functional tests (for CIPN patients)

Where it's running

  • Institute of Physical Medicine and Rehabilitation, University Hospital Salzburg
    Salzburg, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.